BioSpace News Archive

North America is expected to dominate the global blood gas and electrolyte analyzer market during the forecast period.

Flood in number of patients experiencing respiratory sickness, improvements in Cough syrup item, and development in older populace drive the development of the worldwide Cough syrup market.

Terumo Blood and Cell Technologies today announced they have established a memorandum of understanding (MOU) for collaboration to develop Innocell™, a novel tumor specific immunotherapy (a therapeutic vaccine) for solid tumors.

Watching a mother mouse gather her pups into the family’s nest trains other female mice without pups to perform the same parenting task, a new study shows.

Cyanotech Corporation announced financial results for the first quarter of fiscal year 2022, ended June 30, 2021.

Mahana Therapeutics has completed a $61 million Series B financing.

Biomerica Inc. (NASDAQ: BMRA) announced today that the Japanese Patent Office has issued a notice of allowance for Biomerica’s first patent pertaining to a revolutionary new treatment option for patients suffering from depression.

Lantern Pharma today announced that the U.S. Food and Drug Administration (FDA) has granted LP-184 Orphan Drug Designation for the treatment of pancreatic cancer.

Skye Bioscience, Inc. announced today that Karam Takhar, VP of Corporate Development and Investor Relations, Skye Bioscience is scheduled to present virtually in the H.C. Wainwright Ophthalmology Conference on Tuesday, August 17 at 7:00 AM ET.

Sorrento Therapeutics, Inc. (NASDAQ: SRNE; “Sorrento”), and Dyadic International, Inc. (NASDAQ: DYAI; “Dyadic”), today announced the signing of a binding term sheet to enter into an exclusive license agreement to develop and commercialize vaccines, therapeutics, and diagnostics for coronaviruses, including Dyadic’s lead COVID-19 vaccine candidate, DYAI-100,